Quarterly report pursuant to Section 13 or 15(d)

WARRANTS (Details Narrative)

WARRANTS (Details Narrative) - USD ($)			3 Months Ended		9 Months Ended
WARRANTS (Details Narrative) - USD ($)	Oct. 16, 2020	Jul. 28, 2020	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jan. 26, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt face amount			$ 18,435,456		$ 18,435,456			$ 20,000,000
Share-Based Payment Arrangement, Tranche One [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt face amount		$ 20,000,000
CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares									33,334
Exercise price of warrants									$ 396
Investment Agreement [Member] \| CFF Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares			50,207		50,207
Exercise price of warrants			$ 283.81		$ 283.81
Weighted average remaining life of warrants					1 year 10 months 9 days
Warrant expire date							Jan. 26, 2025
Fair value of warrants issued					$ 6,215,225
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised		2,873			194,444
Exercise price of warrants		$ 208.8
Loan Agreement [Member] \| K2 Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised		2,873
Warrants outstanding to purchase of common stock shares		2,873
Exercise price of warrants		$ 208.8
Warrant expire date		Jul. 28, 2030
Fair value of warrants issued		$ 472,409
Loan Agreement [Member] \| K2 Warrant [Member] \| Maximum [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Debt face amount		$ 50,000,000
Professional Services Agreement [Member] \| Warrants [Member] \| Investor Relations Service Provider [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants outstanding to purchase of common stock shares	14,000
Exercise price of warrants	$ 32.1
Warrant expire date	Nov. 03, 2025
Fair value of warrants issued	$ 334,740
Warrant [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrants to purchase shares of common stock, exercised			0	0	0	0